Health  Vol.1 No.4 , December 2009
Cost-benefit analysis of screening for diabetic retinopathy among Chinese type 2 diabetes: decision from different perspectives of a population-based study
ABSTRACT
The purpose of this study is to explore whether it is worthwhile to launch a routine diabetic retinopathy (DR) screening for blindness pre-vention among Chinese type 2 diabetes from different perspective based on the popula-tion-based study in Kinmen, Taiwan. A total of 971 community dwelling adults previously di-agnosed with type 2 diabetes in 1991-1993 un-derwent DR screening in 1999-2002 by a panel of ophthalmologists using on-site indirect oph-thalmoscopy and 45-degree color fundus retinal photographs. The cost-benefit analysis is used to evaluate the DR screening. In terms of bene-fit-cost ratio, the different screening programs for DR could save New Taiwan Dollars (NTD) from 14.38 to 36.83 in discounted costs for each dollar incurred in different screening years from the societal viewpoint for Taiwan and save NTD from 0.81 to 1.80 in different screening years from health care payer’s perspective. The av-erage estimate of willingness-to-pay to translate into benefit yields NTD from 937.8 to 4,689 be- nefits per case due to DR screening in different screening years during 10-year follow-up. The net present value of the DR screening were NTD from -167,318 to -307,251.2 in different screening years. In conclusion, it is worthwhile to initial a routine DR screening of Chinese type 2 diabetes for blindness prevention from the societal per-spective but not from consumer decision based on the willingness-to-pay perspective.

Cite this paper
nullPeng, C. , Chou, P. , Tung, T. , Chien, W. , Lee, F. , Chen, S. , Tsai, S. , Liu, C. and Liu, J. (2009) Cost-benefit analysis of screening for diabetic retinopathy among Chinese type 2 diabetes: decision from different perspectives of a population-based study. Health, 1, 304-312. doi: 10.4236/health.2009.14050.
References
[1]   Sanchez-Thorin, J.C. (1998) The epidemiology of diabetes mellitus and diabetic retinopathy. Intern Ophthalmol Clin, 38(2), 11-18.

[2]   Chen, M.S., Kao, C.S., Chang, C.J., Wu, T.J., Fu, C.C. and Chen, C.J. (1992) Prevalence and risk factors of dia-betic retinopathy among non-insulin-dependent diabetic subjects. Am J Ophthalmol, 114(6), 723-730.

[3]   Tung, T.H., Chen, S.J., Liu, J.H., et al. (2005) A commu-nity-based follow-up study on diabetic retinopathy among type 2 diabetics in Kinmen. Eur J Epidemiol, 20(4), 317-323.

[4]   Tung, T.H., Chen, S.J., Shih, H.C., et al. (2006) Assess-ing the natural course of diabetic retinopathy: A popula-tion-based study in Kinmen. Taiwan, Ophthalmic Epide-miol, 13(5), 327-333.

[5]   Bala, M.V., Mauskopf, J.A. and Wood, L.L. (1999) Will-ingness to pay as a measure of health benefits. Pharma-coeconomics, 15(1), 9-18.

[6]   Jampel, H.D., Schwartz, G.F., Robin, A.L., Abrams, D.A., Johnson, E. and Miller, R.B. (2003) Patient preferences for eye drop characteristics: A willingness-to-pay analy-sis. Arch Ophthalmol, 121(4), 540-546.

[7]   Olsen, J.A. and Smith, R.D. (2001) Theory versus prac-tice: A review of “willingness-to-pay” in health and health care. Health Econ, 10(1), 39-52.

[8]   Shih, H.C., Chou, P., Chen, S.J., et al. (2007) A commu-nity-based study of the willingness to pay associated with screening for diabetic retinopathy among type 2 diabetes in Kinmen, Taiwan. J Epidemiol, 17(6), 186-193.

[9]   Chou, P., Liao, M.J., Kuo, H.S., Hsiao, K.J. and Tsai, S.T. (1994) A population survey on the prevalence of diabetes in Kin-Hu, Kinmen. Diabetes Care, 17(9), 1055-1058.

[10]   World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complica-tions: Report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus. Geneva, World Health Organization.

[11]   Wilkinson, C.P., Ferris 3rd, F.L., Klein, R.E., et al. (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Oph-thalmology, 110(9), 1677-1682.

[12]   García-Serrano, J.L., Serrano-Laborda, D., López-Pozas, M., Cabello-Aparicio, C. and Castro-Rosales, L. (2007) The Granada diabetic retinopathy study: Direct screening of 8,244 patients. I Arch Soc Esp Oftalmol, 82(11), 681-689.

[13]   Harvey, J.N., Craney, L., Nagendran, S. and Ng, C.S. (2006) Towards comprehensive population-based screening for diabetic retinopathy: Operation of the North Wales diabetic retinopathy screening programme using a central patient register and various screening methods. J Med Screen, 13(2), 87-92.

[14]   Ackerman, S.J. (1992) Benefits of preventive programs in eye care are visible on the bottom line. A new nation-wide effort to improve eye care for people with diabetes gets backing from a study on the cost-effectiveness of screening for retinopathy. Diabetes Care, 15(4), 580-581.

[15]   Javitt, J.C. and Aiello, L.P. (1996) Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med, 124(1 Pt 2), 164-169.

[16]   Polak, B.C., Crijns, H., Casparie, A.F., et al. (2003) Cost-effectiveness of glycemic control and ophthal-mological care in diabetic retinopathy. Health Policy, 64(1), 89-97.

[17]   Tung, T.H., Shih, H.C., Chen, S.J., et al. (2008) Eco-nomic evaluation of screening for diabetic retinopathy among Chinese type 2 diabetics: A community-based study in Kinmen, Taiwan. J Epidemiol, 18(5), 225-233.

[18]   Health Employer Data and Information Set (1997) Ver-sion 3.0. Washington, DC: National Committee for Qual-ity Assurance, 2.

[19]   Sloan, F.A., Grossman, D.S. and Lee, P.P. (2009) Effects of receipt of guideline recommended care on onset of diabetic retinopathy and its progression. Ophthalmology, 116(8), 1515-1521.

[20]   Klein, R., Klein, B.E, Neider, M.W., Hubbard, L.D., Meuer, S.M. and Brothers, R.J. (1985) Diabetic reti-nopathy as detected using ophthalmoscopy, a nonmydri-atic camera and a standard fundus camera. Ophthalmol-ogy, 92(4), 485-491.

[21]   Ekoe, J.M., Zimmet, P. and Williams, R. (2001) The epi-demiology of diabetes mellitus: An international perspec-tive. John Wiley & Sons, Inc.

[22]   Byrt, T. (1996) How good is that agreement. Epidemiol-ogy, 7(5), 561.

[23]   Aiello, L.P., Gardner, T.W., King, G.L., et al. (1998) Dia-betes retinopathy. Diabetes Care, 21(1), 143-156.

 
 
Top